Mirjana Maletic-Savatic

Title: Mirjana Maletic-Savatic: Innovator in Neurogenesis Research

Introduction

Mirjana Maletic-Savatic is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of neurogenesis through her innovative research and patent work. Her dedication to understanding and treating neurological disorders has positioned her as a key figure in medical research.

Latest Patents

Mirjana holds a patent for "Small-molecule modulators of the orphan nuclear receptor TLX." This patent describes small molecules that act through the ligand binding domain of nuclear receptor TLX (NR2E1). The invention focuses on promoting neurogenesis and treating disorders associated with nuclear receptor TLX, including neurological conditions such as Alzheimer's disease. The patent also provides compounds according to Formula II, along with pharmaceutically acceptable salts or isomers thereof. She has 1 patent to her name.

Career Highlights

Mirjana is affiliated with the Baylor College of Medicine, where she conducts her research. Her work has garnered attention for its potential impact on treating debilitating neurological disorders. She has been instrumental in advancing the understanding of neurogenesis and its implications for human health.

Collaborations

Mirjana has collaborated with notable colleagues, including Prasanna Kandel and Srinivas Chamakuri. These partnerships have further enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Mirjana Maletic-Savatic's contributions to neurogenesis research and her patented innovations highlight her commitment to advancing medical science. Her work continues to inspire and pave the way for future breakthroughs in treating neurological disorders.